To determine the prevalence of self-reported circadian-related sleep disorders, sleep medication and melatonin use in the New Zealand blind population.
Pharmacology, Toxicology and Pharmaceutical Science
4
4%
Other
13
14%
Unknown
35
38%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 June 2020.
All research outputs
#23,329,066
of 34,410,315 outputs
Outputs from PLOS ONE
#143,585
of 224,661 outputs
Outputs of similar age
#130,355
of 167,955 outputs
Outputs of similar age from PLOS ONE
#1,831
of 2,561 outputs
Altmetric has tracked 34,410,315 research outputs across all sources so far. This one is in the 30th percentile – i.e., 30% of other outputs scored the same or lower than it.
So far Altmetric has tracked 224,661 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.2. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 167,955 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2,561 others from the same source and published within six weeks on either side of this one. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.
